Total amount: € 0,00
HOW TO ORDER
A Journal on Angiology
Official Journal of the , the International Union of Phlebology and the
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899
International Angiology 2010 August;29(4):355-61
Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy
Evola G., Novo G., Amoroso G., Guttilla D., Lo Coco L. 2, Guagliardo M. 3, Lupo A. 3, Averna M. R. 4, Giambanco V. 3, Miller V. 5, Novo S. 2 ✉
1 Division of Cardiovascular Diseases, Department of Internal Medicine and Cardiovascular Diseases, University Hospital “Paolo Giaccone”, University of Palermo, Palermo, Italy
2 Laboratory of Haemostasis and Thrombosis, Division of Haematology, Department of Internal Medicine and Cardiovascular Diseases, University Hospital “Paolo Giaccone”, University of Palermo, Palermo, Italy
3 Second Division of Obstetrics and Gynaecology, ARNAS Hospital, Palermo, Italy
4 Department of Internal Medicine and Emerging Pathologies, University of Palermo, Palermo, Italy
5 Laboratory of Biochemistry, Department of Surgery, Physiology and Biophysics, Mayo Clinic of Rochester, MN, USA
AIM: We evaluated the changes of lipidic and coagulative pattern during menopause and the influence of hormone replacement therapy (HRT) on these parameters.
METHODS: We considered 158 patients divided into 2 groups: Group I consisted of 127 women in physiological/surgical menopause and Group II of 31 women with childbearing potential. Subsequently, we considered a group III formed of 34 patients from menopausal women (group I) who underwent three months of HRT. We evaluated total-cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), triglycerides (TG), lipoprotein (a) (Lpa), fibrinogen, antithrombin III (ATIII), factor VII (FVII) and tissue factor pathway inhibitor (TFPI).
RESULTS: We found a worse lipid profile in the post-menopausal group compared to controls (TC 243.8±29.7 vs 217.9±32.7 mg%, P=0.002; TG 121.5±68.4 vs 88.6±53.0 mg%, P=0.039; LDL-C 163.0±27.9 vs 136.2±29.6 mg%, P=0.004; HDL-C 60.9±14.9 vs 64.1±14.6 mg%, P=ns). With regard to the coagulative pattern, fibrinogen was significantly higher in the post-menopausal group (fibrinogen: 273.3±67.4 vs 243.8±39.5 mg%, P=0.013; ATIII 112.2±11.7 vs 117.5±12.7% %, P=0.059; FVII 121.6±11.3 vs 117.6±10.8 mg%, P=ns; TFPI activity 2.5±2.3 vs 2.1±1.1 U/mL, P=ns; TFPI antigen 120±38 vs 127±39 U/mL, P=ns). Comparing the same parameters, before and after three months of HRT, in patients of Group III we observed a significant improvement of TC and TG levels (TC from 232.3±42.7 to 215.2±37.6 mg%, P=0.0001; TG from 103.7±56.8 to 95.0±44.3 mg%, P=0.059; HDL-C from 62.3±12.9 to 63.6±12.6 mg%, P=ns; LDL-C from 149.3±38.7 to 132.6±34.5 mg%, P=0.0001). The following changes were observed with regard to coagulative parameters: fibrinogen from 270.9±69.4 to 253.2±56.2 mg%, P=0.07; ATIII from 113.5±11.4 to 110.8±13.2 mg%, P=0.198; FVII from 108.6±18.0 to 104.4±17.5 mg%, 0.014. TFPI activity from 2.6±2.3 to 2.3±1.4 U/ml, P=ns; TFPI antigen from 68±13 to 87±22 U/mL, P=0.001.
CONCLUSION: Our data confirm the presence of an alteration in lipidic and coagulative pattern in post menopausal women and positive changes after HRT.